 |
| Powered by phpBay Pro |
Brand Erosion Post-Patent Expiry - An analysis of small molecule brand erosion post-patent expiry
Introduction
Pharma is facing slowing sales growth in the developed pharmaceutical markets, driven by increasing generic competition. However, the speed and severity of brand erosion is by no means equal across countries, prescribing setting, therapy area and formulation type; factors which are of key importance when managing and forecasting branded drug sales.
Features and benefits
* Analyzes brand erosion (in terms of volume and value) in the US, Japan, France, Germany, Italy, Spain, UK, Australia China and Russia
* Assesses brand erosion across the two major prescribing settings (retail and hospital)
* Examines brand erosion across the various different therapy areas
* Analyzes brand erosion according to drug formulation (oral, oral long lasting, parenteral and other formulation types)
Highlights
Brands tended not to experience generic erosion in China following patent expiry since they often face generic competition from the outset, and instead continue to grow both in terms of volume and value.Brand erosion was greater in terms of speed and severity in the hospital setting most likely reflecting the greater brand loyalty among patients in the retail setting.In terms of erosion by therapy areas, sales and volume erosion was the greatest among infectious disease, oncology, and cardiovascular small molecule brands.
Your key questions answered
* Evaluate the evolving prescription pharmaceutical landscape and how this is being impacted by generics
* Quantify sales and volume erosion across 10 major pharmaceutical markets according to prescribing setting, therapy areas, and drug formulation
* Assess drivers and resistors for the uptake of generic drugs in each market
Table of Contents :
Executive Summary
Introduction
Strategic scoping and focus
Key Findings
Brand erosion by country
Brand erosion by prescribing setting (retail versus hospital)
Brand erosion by therapy area
Brand erosion by formulation
Overview of drugs analyzed
Related reports
2. OVERVIEW – SMALL MOLECULE BRAND EROSION
Overview – overview of drugs analyzed
Overview – mean level of brand erosion across the world's major markets
Overview – generics market dynamics
Generics volume uptake
Generics value uptake
Generics market size
Overview – generics drivers and resistors
US – Generics drivers and resistors
Japan – Generics drivers and resistors
France – Generics drivers and resistors
Germany – Generics drivers and resistors
Italy – Generics drivers and resistors
Spain – Generics drivers and resistors
UK – Generics drivers and resistors
China – Generics drivers and resistors
Brazil – Generics drivers and resistors
India – Generics drivers and resistors
Russia – Generics drivers and resistors
Australia – Generics drivers and resistors
Overview – brand erosion in the retail and hospital setting
Retail and hospital erosion by country
Overview – brand erosion by therapy area
Brand erosion by therapy area – Infectious diseases
Brand erosion by therapy area – Cardiovascular
Brand erosion by therapy area – Oncology
Brand erosion by therapy area – Central Nervous System
Brand erosion by therapy area – Respiratory
Brand erosion by therapy area – Metabolic disorders
Brand erosion by therapy area – Immunology and inflammation
Brand erosion by therapy area – Other
Overview – brand erosion by drug formulation
Brand erosion by drug formulation – Oral normal
Brand erosion by drug formulation – Oral long lasting
Brand erosion by drug formulation – Parenteral
Brand erosion by drug formulation – Other
3. US – SMALL MOLECULE BRAND EROSION
US – overview of drugs analyzed
US – mean level of brand erosion
US – brand erosion in the retail and hospital setting
US – brand erosion by therapy area
US – brand erosion by drug formulation
4. JAPAN – SMALL MOLECULE BRAND EROSION
Japan – overview of drugs analyzed
Japan – mean level of brand erosion
Japan – brand erosion in the retail and hospital setting
Japan – brand erosion by therapy area
Japan – brand erosion by drug formulation
5. FRANCE – SMALL MOLECULE BRAND EROSION
France – overview of drugs analyzed
France – mean level of brand erosion
France – brand erosion in the retail and hospital setting
France – brand erosion by therapy area
France – brand erosion by drug formulation
For some-more information, Great fully visit:
About the Author
We specialize in providing online market business information on market research reports, books, magazines, conference booking at competitive prices, and strive to provide excellent and innovative service to our customers.
3 small 1991 cars from Japan reviewed & driven
|
 BN Tsumori Chisato Multi Dot Leather Wallet with Box small Made in Japan  US $265.00
|
 japanese WW2 BINOCULAR small size WWII japan military US $265.00
|
 RARE HTF WDCC SMALL WORLD JAPAN SET MIB US $250.00
|
 JAPAN COIN 1 YEN 1881 YEAR 14 1 SMALL CHOP XF US $250.00
|
 Seki Japan Japanese G SAKAI Small Folding Pocket Knife US $250.00
|
 Yayoi Kusama Soft sculpture Pumpkin Size S small Japan Art US $249.00
|
![ANCIENT TALES FOLK LORE OF JAPAN Hardcover] by Sm](http://www.peterconover.com/images/e/320388657018_0.jpg)
 ETRO PAISLEY TIERED NECK DRESS SMALL ONLY FOR JAPAN US $207.20
|
 Meiji Techno Japan Microscope Objective SM Plan 100x US $205.43
|
 Small Vintage Windup CK Sedan Car Tin Toy Japan US $200.00
|
 Japan 1951 MI Bloc 38 small creases MNH VF US $185.00
|
 HONDA OEM ABS SENSOR MADE IN JAPAN REAR RIGHT AND LEFT ACCORD 90 93 US $183.30
|
 Japan Occ China Shantung Opt Small Char Set4 Chan U$252 US $180.00
|
 Saint Seiya Myth Cloth BANDAI Gemini Hades Ver Japan SM06 US $180.00
|
 WDCC SMALL WORLD JAPAN BROTHER SISTER GATE WALT DISNEY US $179.00
|
| Powered by phpBay Pro |
Tags: architecture, design, japan, japan small apartment, japan small cap etf, japan small cap fund, japan small cap index, japan smaller capitalization fund, tokyo, travel